Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients

NCT00646841 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Doxazosin gastrointestinal therapeutic system (GITS)

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.